Esperion Therapeutics, Inc. (ESPR)
2.04
-0.01
(-0.49%)
USD |
NASDAQ |
Apr 17, 16:00
2.025
-0.02
(-0.74%)
Pre-Market: 08:27
Esperion Therapeutics SG&A Expense (Quarterly) : 41.43M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Nektar Therapeutics | 11.18M |
| Harrow, Inc. | 43.31M |
| Corcept Therapeutics, Inc. | 130.24M |
| Catalyst Pharmaceuticals, Inc. | 48.23M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |